Denmark Research-grade Proteins Market Size & Outlook
Denmark research-grade proteins market, 2018-2030 (US$M)
Related Markets
Denmark research-grade proteins market highlights
- The Denmark research-grade proteins market generated a revenue of USD 9.0 million in 2023 and is expected to reach USD 22.6 million by 2030.
- The Denmark market is expected to grow at a CAGR of 14% from 2024 to 2030.
- In terms of segment, cytokines & growth factors was the largest revenue generating product in 2023.
- Cytokines & Growth Factors is the most lucrative product segment registering the fastest growth during the forecast period.
Research-grade proteins market data book summary
| Market revenue in 2023 | USD 9.0 million |
| Market revenue in 2030 | USD 22.6 million |
| Growth rate | 14% (CAGR from 2023 to 2030) |
| Largest segment | Cytokines & growth factors |
| Fastest growing segment | Cytokines & Growth Factors |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
Other key industry trends
- In terms of revenue, Denmark accounted for 0.9% of the global research-grade proteins market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK research-grade proteins market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 141.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research-grade Proteins Market Scope
Research-grade Proteins Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Denmark research-grade proteins market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 24.44% in 2023. Horizon Databook has segmented the Denmark research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
Denmark is a European country with the fastest-growing biotech investment. Danish biotech businesses have secured venture capital investment of USD 434 million in 2021, an 11.8-fold increase over the past 5 years, demonstrating the second-fastest growth rate in Europe after the Netherlands.
These investments are anticipated to drive the demand for outsourcing activities, boosting market growth in the years to come. Furthermore, Denmark is home to key market players, such as Lonza & Fujifilm, actively investing in the country to expand their market presence.
For instance, in June 2020, Fujifilm announced an investment of USD 928 million at its Denmark site to expand the facility’s bulk drug manufacturing capacity and finish/fill capabilities.
Reasons to subscribe to Denmark research-grade proteins market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Denmark research-grade proteins market databook
-
Our clientele includes a mix of research-grade proteins market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into Denmark research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Denmark research-grade proteins market size, by product, 2018-2030 (US$M)
Denmark Research-grade Proteins Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
